tiprankstipranks
Archean Chemical Industries Ltd. (IN:ACI)
:ACI
India Market
Want to see IN:ACI full AI Analyst Report?

Archean Chemical Industries Ltd. (ACI) AI Stock Analysis

1 Followers

Top Page

IN:ACI

Archean Chemical Industries Ltd.

(ACI)

Select Model
Select Model
Select Model
Neutral 52 (OpenAI - 5.2)
Rating:52Neutral
Price Target:
₹603.00
▲(7.26% Upside)
Action:Reiterated
Date:05/13/26
The score is held back primarily by deteriorating fundamentals—especially weak cash conversion and negative free cash flow—along with a relatively expensive valuation (high P/E, low yield). Technical indicators are mixed and only mildly supportive, and the balance sheet remains generally healthy but with rising leverage.
Positive Factors
Specialty product mix & export orientation
Archean’s focus on industrial salt and bromine-derived specialty chemicals and meaningful exports supports durable demand diversity. Specialty and export exposure underpin pricing power with industrial customers and higher value add versus commoditized chemicals, aiding long-term revenue resilience.
Negative Factors
Weak cash generation and negative FCF
Sharp deterioration in cash conversion and recurring negative free cash flow reduce financial flexibility. Sustained negative FCF can force higher borrowing or defer maintenance and growth capex, weakening the firm’s ability to fund operations and strategic initiatives without raising costlier capital.
Read all positive and negative factors
Positive Factors
Negative Factors
Specialty product mix & export orientation
Archean’s focus on industrial salt and bromine-derived specialty chemicals and meaningful exports supports durable demand diversity. Specialty and export exposure underpin pricing power with industrial customers and higher value add versus commoditized chemicals, aiding long-term revenue resilience.
Read all positive factors

Archean Chemical Industries Ltd. (ACI) vs. iShares MSCI India ETF (INDA)

Archean Chemical Industries Ltd. Business Overview & Revenue Model

Company Description
Archean Chemical Industries Limited manufactures and sells specialty marine chemicals in India and internationally. It offers bromine for use in pharmaceuticals, agrochemicals, water treatment products, flame retardants, additives, oil and gas ind...
How the Company Makes Money
ACI primarily makes money by manufacturing and selling specialty marine chemicals, with revenue driven mainly by (1) industrial salt sales and (2) bromine and bromine-derivative product sales to industrial customers. The company generates sales th...

Archean Chemical Industries Ltd. Financial Statement Overview

Summary
Financials are mixed and trending weaker: profitability remains positive but has cooled sharply (net margin down to ~10% in 2026 after ~24–27% in 2023–2024) alongside three straight years of revenue decline. The balance sheet is still generally healthy with moderate leverage (debt-to-equity ~0.24), but leverage has risen quickly. The biggest drag is cash flow: operating cash flow covers only ~30% of net income and free cash flow is negative in 2025–2026, reducing flexibility.
Income Statement
62
Positive
Balance Sheet
70
Positive
Cash Flow
38
Negative
BreakdownTTMMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Income Statement
Total Revenue11.21B10.81B10.41B13.30B14.40B11.30B
Gross Profit10.85B8.50B10.49B12.16B14.37B8.50B
EBITDA3.17B2.39B3.11B5.06B6.77B4.79B
Net Income1.58B1.07B1.62B3.19B3.83B1.88B
Balance Sheet
Total Assets0.0026.65B23.93B20.56B17.55B15.31B
Cash, Cash Equivalents and Short-Term Investments2.43B610.77M2.55B3.95B2.31B695.11M
Total Debt0.004.66B2.35B978.23M693.85M9.00B
Total Liabilities-18.64B7.32B5.29B3.54B3.24B12.69B
Stockholders Equity18.64B19.34B18.64B17.02B14.31B2.62B
Cash Flow
Free Cash Flow0.00-2.50B-873.38M1.71B3.96B2.18B
Operating Cash Flow0.001.32B1.76B3.79B4.96B3.15B
Investing Cash Flow0.00-2.96B-2.46B-3.07B-2.90B-1.10B
Financing Cash Flow0.001.64B649.80M-325.69M-2.12B-2.24B

Archean Chemical Industries Ltd. Technical Analysis

Technical Analysis Sentiment
Negative
Last Price562.20
Price Trends
50DMA
586.24
Negative
100DMA
570.77
Negative
200DMA
599.87
Negative
Market Momentum
MACD
-18.35
Positive
RSI
28.63
Positive
STOCH
13.60
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:ACI, the sentiment is Negative. The current price of 562.2 is below the 20-day moving average (MA) of 585.61, below the 50-day MA of 586.24, and below the 200-day MA of 599.87, indicating a bearish trend. The MACD of -18.35 indicates Positive momentum. The RSI at 28.63 is Positive, neither overbought nor oversold. The STOCH value of 13.60 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:ACI.

Archean Chemical Industries Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
81
Outperform
₹76.48B6.673.68%-1.51%35.32%
69
Neutral
₹124.16B34.560.15%22.01%75.16%
65
Neutral
₹52.67B-46.403.11%7.73%92.87%
62
Neutral
₹70.61B11.492.80%6.87%27.25%
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
60
Neutral
₹38.00B16.520.19%-7.72%0.07%
52
Neutral
₹64.38B67.830.78%3.85%-34.10%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IN:ACI
Archean Chemical Industries Ltd.
521.55
-97.95
-15.81%
IN:GNFC
Gujarat Narmada Valley Fertilizers & Chemicals Ltd.
522.05
25.89
5.22%
IN:GSFC
Gujarat State Fertilizers & Chemicals Limited
174.80
-26.60
-13.21%
IN:GUJALKALI
Gujarat Alkalies & Chemicals Ltd.
713.50
129.98
22.28%
IN:PRIVISCL
Privi Speciality Chemicals Limited
3,266.20
923.58
39.43%
IN:REFEX
Refex Industries Limited
279.00
-126.21
-31.15%

Archean Chemical Industries Ltd. Corporate Events

Archean Chemical releases FY26 earnings call investor presentation
May 12, 2026
Archean Chemical Industries Ltd. has released an investor presentation tied to its earnings call for the quarter and full year ended March 31, 2026. The materials have been filed with Indian stock exchanges and made available on the company’...
Archean Chemical Unveils FY26 Results, Dividend and Board Reappointments
May 11, 2026
Archean Chemical Industries reported its audited standalone and consolidated financial results for the quarter and full year ended 31 March 2026, with audit opinions remaining unmodified, signaling clean assurance on its accounts. The company plan...
Archean Chemical Reappoints Statutory Auditors and Independent Directors to Strengthen Governance
May 11, 2026
Archean Chemical Industries Ltd. has approved the re-appointment of PKF Sridhar Santhanam LLP as its statutory auditors for a second four-year term, starting from the conclusion of its 17th Annual General Meeting in June 2026 and running through ...
Archean Chemical Reappoints Statutory Auditors and Independent Directors to Bolster Governance Stability
May 11, 2026
Archean Chemical Industries Ltd. has reappointed PKF Sridhar Santhanam LLP as its statutory auditors for a second four-year term, starting after the upcoming 17th Annual General Meeting in June 2026 and extending through the 21st AGM in 2030, sub...
Archean Chemical Recommends Final Dividend, Sets Key Dates for FY 2025-26
May 11, 2026
Archean Chemical Industries Ltd.’s board has recommended a final dividend of Rs 2.50 per equity share of Rs 2 each for the financial year ended March 31, 2026, to be paid within 30 days of shareholder approval at the upcoming annual general ...
Archean Chemical Clarifies Non-Large Corporate Status Under SEBI Norms
May 11, 2026
Archean Chemical Industries Ltd. has clarified that it does not qualify as a Large Corporate under recent SEBI guidelines, based on its current borrowing profile and regulatory criteria. As of March 31, 2026, the company reported long-term bank lo...
Archean Chemical Secures SEBI Compliance Certificate for Demat Processes
Apr 15, 2026
Archean Chemical Industries Ltd. has notified the stock exchanges that it has received a compliance certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended March 31, 2026. The registra...
Archean Chemical to Merge Two Idealis Subsidiaries in Group Reorganisation
Mar 19, 2026
Archean Chemical Industries Ltd. has approved the merger of its wholly owned subsidiary Idealis Chemicals Pvt. Ltd. with Idealis Mudchemie Pvt. Ltd., a wholly owned subsidiary of Idealis and step-down subsidiary of Archean. Both entities, headquar...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: May 13, 2026